An accurate & sensitive stability indicating analytical method has been developed for the control of impurities in Bosentan API. Four impurities (impurity A, B, C & D) were isolated from the API and were characterized by spectroscopic studies. An HPLC equipped with quaternary gradient pumps, variable wavelength UV detector attached with data recorder and integrator software was used. A Zorbax SB-C 8 (250 x 4.6mm, 5µ) column at 25°C was used with a flow rate of 1.0 ml/min and the compounds were detected at 220 nm. Mobile phase A consisted of buffer (1gm of octane-1-sulfonic acid sodium salt and 1 ml triethyl amine in 1 liter of water, pH adjusted to 2.5 with perchloric acid) and methanol was used as mobile phase B. The method was validated according to the ICH guidelines with respect to specificity, linearity, range, accuracy, precision, limit of detection & quantification. Robustness testing was also conducted to evaluate the effect of minor changes to the chromatographic system and to establish appropriate system suitability parameters. All of them were found to be satisfactory for the method. Thus the method can very well be implemented in quality control laboratories and in stability testing departments.
INTRODUCTION
Bosentan is chemically known as 4-tert-butyl-N-[6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-[2,2´]-bipyrimidin-4-yl]-benzenesulfonamide monohydrate having molecular formula C 27 H 29 N 5 O 6 S.H 2 O, molecular weight of 569. 64 and CAS NO: [157212-55-0] . (Figure 1 ). It is competitive antagonist of endothelin -1 receptor acts on endothelin A and endothelin present smooth mussels of pulmonary vessels (Wikipedia Bosentan, Drugbank Bosentan, Chemblink Bosentan). It is under development for the treatment of hypertension and chronic heart failure. Bosentan is not official in any pharmacopoeia. A literature survey revealed that only few analytical techniques including Liquid Chromatography -Mass Spectrophotometry (Lausecker et al., 2000 and 1995; Dell et al., 2002) , High performance liquid chromatography (Vijaya et al., 2008) , Spectrophotometry (Mathrusri et al., 2011; Ashok et al., 2011) have been employed for the determination of bosentan. So there is need to develop a simple and precise method for the determination of related substances in Bosentan. Hence, an attempt has been made to develop a simple, efficient and selective method for the analysis of related substances in Bosentan API. HPLC instrumentation with UV detection, which is readily available in most analytical & pharmaceutical laboratories was used.  HPLC grade methanol and water were used.
ND = Not detected

MATERIALS
 All other chemicals including octane sulfonic acid sodium salt, triethyl amine, perchloric acid 70%, sodium hydroxide, hydrochloric acid and hydrogen peroxide (50%) were of GR grade.
METHODS
Instrumentation and liquid chromatographic conditions:
A High Performance Liquid Chromatography equipped with a quaternary gradient pumps, variable wavelength UV detector attached with data recorder and integrator software was used. A Zorbax SB-C 8 (250 x 4.6mm, 5µ) column at 25°C was used in the final method. Flow rate of mobile phase was set at 1.0ml/min with an injection volume of 20l and detection was done at 220 nm. A mixture of water, methanol and methylene chloride (20: 80: 0.05, v/v/v) and water: methanol (20:80, v/v) were used as diluent A and diluent B respectively. Mobile phase A consisted of buffer and methanol was used as mobile phase B. Buffer was prepared by dissolving 1gm of octane-1-sulfonic acid sodium salt in 1000ml of water and then adding 1 ml of triethylamine to it and finally adjusting the pH to 2.5 with perchloric acid. The initial composition of the mobile phase gradient was set at mobile phase A & B in a ratio of 55: 45 (Table 1) . Selection of columns and mobile phase: Five different columns with different chemistry & length were used during the method development-BDS Hypersil C 8 (250 x 4.6 mm, 5µ), Inertsil ODS 3V (150 x 4.6 mm, 5µ) & Zorbax SB-C8 (250 x 4.6 mm, 5µ), Inertsil C 8 -3 (250 x 4.6 mm, 5µ) and Waters Symmetry C 8 (250 x 4.6 mm, 5µ). Different combinations of mobile phases were tried out which included buffer (1.0 gm octane sulfonic acid sodium salt in 0.1% triethyl amine in water, pH 2.5 with perchloric acid), methanol.
Optimization of gradient:
Gradient was optimized using different run time and composition to get proper resolution between impurities and main peak. 4 different gradient programmes were used during development.
System suitability: The relative standard deviation determined from the six replicate injections of reference solution (a) should not be more than 5.0%. In reference solution (f), resolution between impurity A and impurity B should not be less than 1.5 and resolution between impurity D and main peak should not be less than 1.5.
Validation
Specificity: To check the specificity of the method the compound was subjected to stress condition under different sets of conditions like temperature, humidity, acid, base, oxidation and photo degradation. Chromatograms were checked for appearance of any extra peak due to degradation of the analyte under stress conditions. Purity of the main peak was also recorded. Selectivity was confirmed by injecting Impurity A, Impurity B, Impurity C, Impurity D.
Effect of diluent: Diluent was injected in to the column to check the interference from the diluent at the retention time of the main peak. It was observed that diluent A does not interfere with retention time of the main peak or any other impurity.
Degradation with acid: 0.1N HCl was used for acid degradation study. Samples were injected at 0, 12 & 24 hrs and also after refluxing for 4 hrs.
Degradation with base: 0.1N NaOH was used to study the degradation of the sample in presence of base. The samples were exposed to base and were injected at 0, 12 & 24 hrs and also after refluxing the sample for 4 hrs.
Oxidative degradation: To check oxidative degradation, samples were exposed to a 3% hydrogen peroxide solution. They were injected at 0, 12 & 24 hrs of exposure. One sample was refluxed with the peroxide solution for 4 hrs and the same was also injected.
Effect of temperature, humidity and light: Samples were also analyzed after exposing it at 105°C for 24 hrs, at 40ºC and 75% humidity for 24 hrs and also at exposure to light for a period equivalent to about 1.2 million lux hrs. Selectivity, Impurity A, Impurity B, Impurity C, Impurity D were injected separately as well as after spiking into the analyte to check their interference with main peak.
Linearity and range:
Solutions of lower concentrations of Impurity A, Impurity B, Impurity C, Impurity D and Bosentan were prepared and each concentration was injected on the same day. The data generated was analyzed by linear regression analysis to calculate the slope, intercept and the correlation coefficient. Linearity graphs were plotted from range LOQ, 50%, 75%, 100%, 125% and 150% levels.
Accuracy:
The accuracy of the method was determined by spiking the known impurities at 50%, 100% and 150% w/w of the specified limit and at LOQ level. The recovery of Impurity A, Impurity B, Impurity C, Impurity D was determined.
Limit of detection (LOD) & quantification (LOQ):
The limit of detection was determined from the linearity values of related substances experiment wherein lower concentrations of each Impurity A, Impurity B, Impurity C, Impurity D and Bosentan were analyzed.
Precision: System precision: System precision was carried out during ruggedness experiment. The RSD for six replicate injections of reference solution (a) were calculated.
Method precision: Method precision was performed by estimating the related substances in three control samples & six spiked samples on the same day. This experiment was carried out as a part of the ruggedness experiment.
Ruggedness (intermediate precision):
Ruggedness was performed by estimating the related substances in three control & six spiked samples by two different analysts using different HPLC columns on different instruments on two different days
Robustness:
Robustness of the method was tested by deliberate changes in the column temperature (± 5°C), wavelength (±2nm), column (same make, different lot no.), flow rate (± 0.2 ml/min), pH of buffer and also buffer concentration.
Mass spectrometry: APCI mass spectra of all isolated impurities were recorded on a PE -Sciex API 3000 mass spectrophotometer. The samples were introduced to the mass spectrophotometer through the direction injection mode methanol.
RESULTS AND DISCUSSION
Selection of column and mobile phase: Out of the trials performed on five different columns, Zorbax SB-C8 resolved all the impurities. Observations have been summarized in Table 1 . Final mobile phase consisted of buffer and methanol.
Optimization of gradient:
Observations on the trials for optimizing the gradient programme have been summarized in Table 2 .
The final optimized programme has been presented in Table 3 . Degradation with acid: Acid degradation study showed that the sample was stable at 0 and 12 hrs. 0.54 % degradation was observed at 24 hrs. The refluxed sample also showed 0.54% degradation.
Degradation with base: Minor degradation was observed at 0, 12 & 24 hrs. But the refluxed sample showed almost 3.54% degradation.
Oxidative degradation: No degradation has been observed at 0, 12 & 24 hrs but the refluxed sample was degraded to an extent of 1.24%.
Effect of temperature, humidity and light: It was observed that bosentan undergoes minor degradation when exposed to temperature. It was stable on exposure to relative humidity of 75% and on exposure to light. Selectivity: It was observed that Impurity A, Impurity B, Impurity C, Impurity D did not interfere with bosentan peak. This showed that the method was selective for estimation of related substances in bosentan.
Linearity and range:
The method was found to be linear over a range of 0.3750 μg/ml to 1.1250 μg/ml for Impurity A, Impurity B, Impurity C, Impurity D and 0.2500 μg/ml to 0.7500 μg/ml for Bosentan with correlation coefficient greater than 0.99 (Table 4) . Accuracy: Accuracy was determined from the recovery study. The recovery of Impurity A, Impurity B, Impurity C and Impurity D was within the prescribed range of 80-120% for LOQ level & 90% -110% for 50 -150% levels.
Limit of detection (LOD) & quantification (LOQ):
The LOD concentration was found to be 0.04 ppm i.e. 0.01% (w/w) of RS concentration for Impurity A & Impurity C and 0.04 ppm i.e. 0.01% (w/w) of RS concentration for Impurity B, Impurity D & Bosentan. The RSD for six replicate injections of Impurity A, Impurity B, Impurity D, Bosentan and Impurity C were found to be 14.88%, 13.00%, 16.14%, 11.86% & 12.15% respectively. The LOQ concentration was found to be 0.11ppm i.e. 0.02% (w/w) of RS concentration for Impurity A & Impurity B and 0.08 ppm i.e. 0.02% (w/w) of RS concentration for Impurity C & Bosentan and 0.09 ppm i.e. 0.02% (w/w) of RS concentration for Impurity D. The RSD for six replicate injections of Impurity A, Impurity B, Impurity D, Bosentan and Impurity C were found to be 7.58%, 8.46%, 4.30%, 6.46% & 4.58% respectively. (Table  5) . Precision: System precision: System precision was determined in terms of %RSD for six replicate injections of reference solution (a) and it was found to be 0.99 % for Bosentan (Table 6 ). (Table 7) . Change in column: This experiment was carried out as a part of ruggedness and it was found that the change in column does not affect the estimation of related substances.
Change in flow rate: At a flow rate of 0.8 ml/min, the Bosentan peak appeared at about 33.012 mins whereas the same appeared at 26.731 mins when flow rate was set at 1.2 ml/min.
Change in pH of buffer: It was observed that instead of pH 2.5, when the pH of buffer was adjusted to 2.3, the retention time of bosentan shifted to 30.746 mins and the same was 29.641 mins when the pH was adjusted to 2.7.
Change in buffer concentration: The retention time of bosentan changes over a range of 30.746 mins to 29.641 mins when the buffer concentration was changed over a range of 0.9 g/l to 1.1 g/l.
Thus the method was robust and was not affected by any small changes in the experimental conditions. 
CONCLUSIONS
On the basis of several trials a stability indicating analytical method has been developed for the related substances of Bosentan by HPLC. The method is able to separate all process impurities as well as degradation impurities from the peak of Bosentan. The method has been established to be specific, accurate, precise, linear, reproducible, and a robust one and is therefore suitable for routine analysis of bosentan. Method validation studies have been performed as per ICH guidelines, and hence it can very well be implemented in quality control laboratories and in stability testing departments. 
